Value of laparoscopic splenectomy as salvage treatment for relapsed thrombocytopenia after partial splenic arterial embolization

Digestive Surgery

Volumn 27, Issue 6, 2011, Pages 515-520

  Hashimoto, Naotaka ^a   Akahoshi, Tomohiko ^a   Tomikawa, Morimasa ^a   Kawanaka, Hirofumi ^b   Konishi, Kozo ^a   Uehara, Hideo ^a   Kinjo, Nao ^a   Korenaga, Daisuke ^b   Takenaka, Kenji ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka City Hospital   (Japan)

Author keywords

Hepatitis C virus; Hypersplenism; Laparoscopic splenectomy; Partial splenic arterial embolization; Thrombocytopenia

Indexed keywords

AGED; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HUMAN; HYPERSPLENISM; LAPAROSCOPY; LIVER CIRRHOSIS; MALE; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; SALVAGE THERAPY; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VASCULARIZATION;

AGED; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYPERSPLENISM; LAPAROSCOPY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECURRENCE; SALVAGE THERAPY; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 78650649530     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320331     Document Type: Article

References (33)

1. Aster RH: Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 1966; 45: 645-657.
2. Wang CS, Yao WJ, Wang ST, et al: Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin Infect Dis 2004; 39: 790-796.
3. McHutchison JG, Lawitz EJ, Shiffman ML, et al: Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009; 361: 580-593.
4. Annicchiarico BE, Siciliano M, Avolio AW, et al: Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation. Transplant Proc 2008; 40: 1918-1920.
5. Fried MW, Shiffman ML, Reddy KR, et al: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
6. Yamane A, Nakamura T, Suzuki H, et al: Interferon-2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 2008; 112: 542-550.
7. Everson GT, Hoefs JC, Seeff LB, et al: Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT-C trial. Hepatology 2006; 44: 1675-1684.
8. Amin MA, El Gendy MM, Dawoud IE, et al: Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg 2009; 33: 1702-1710.
9. Miyake Y, Ando M, Kaji E, et al: Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Hepatol Res 2008; 38: 980-986.
10. Moreno A, Barcena R, Blazquez J, et al: Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin. Antivir Ther 2004; 9: 1027-1030.
11. Pålsson B, Verbaan H: Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2005; 17: 1153-1155.
12. Sangro B, Bilbao I, Herrero I, et al: Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993; 18: 309-314.
13. Akahoshi T, Tomikawa M, Korenaga D, et al: Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg Endosc 2010; 24: 680-685.
14. Hirooka M, Ishida K, Kisaka Y, et al: Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma. Hepatol Res 2008; 38: 1172-1177.
15. Ikegami T, Shimada M, Imura S: Recent role of splenectomy in chronic hepatic disorders. Hepatol Res 2008; 38: 1159-1171.
16. Kawanaka H, Akahoshi T, Kinjo N, et al: Technical standardization of laparoscopic splenectomy harmonized with hand-assisted laparoscopic surgery for patients with liver cirrhosis and hypersplenism. J Hepatobiliary Pancreat Surg 2009; 16: 749-757.
17. Morihara D, Kobayashi M, Ikeda K, et al: Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res 2009; 39: 439-447.
18. Watanabe Y, Horiuchi A, Yoshida M, et al: Significance of laparoscopic splenectomy in patients with hypersplenism. World J Surg 2007; 31: 549-555.
19. Afdhal N, McHutchison J, Brown R, et al: Thrombocytopenia associated with chronic liver disease. J Hepatol 2008; 48: 1000-1007.
20. Tomikawa M, Akahoshi T, Sugimachi K, et al: Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol 2010; 25: 397-402.
21. Lee CM, Leung TK, Wang HJ, et al: Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 2007; 13: 619-622.
22. Hayashi H, Beppu T, Masuda T, et al: Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007; 22: 1638-1642.
23. Yoshida H, Mamada Y, Taniai N, et al: Longterm results of partial splenic artery embolization as supplemental treatment for portalsystemic encephalopathy. Am J Gastro - enterol 2005; 100: 43-47.
24. Hayashi H, Beppu T, Okabe K, et al: Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 2008; 95: 744-750.
25. Zhu K, Meng X, Qian J, et al: Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis 2009; 41: 411-416.
26. Krivit W, Giebink GS, Leonard A: Overwhelming postsplenectomy infection. Surg Clin North Am 1979; 59: 223-233.
27. Hosea SW, Burch CG, Brown EJ, et al: Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet 1981;i:804-807.
28. Hosea SW, Brown EJ, Hamburger MI, et al: Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 1981; 304: 245-250.
29. Holdsworth RJ, Irving AD, Cuschieri A: Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78: 1031-1038.
30. Cobb WS, Heniford BT, Burns JM, et al: Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc 2005; 19: 418-423.
31. Litwin DE, Darzi A, Jakimowicz J, et al: Hand-assisted laparoscopic surgery (HALS) with the HandPort system: initial experience with 68 patients. Ann Surg 2000; 231: 715-723.
32. Ailawadi G, Yahanda A, Dimick JB, et al: Hand-assisted laparoscopic splenectomy in patients with splenomegaly or prior upper abdominal operation. Surgery 2002; 132: 689-694, discussion 694-696.
33. Yamamoto J, Nagai M, Smith B, et al: Handassisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg 2006; 30: 1520-1525.